In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 8, 2012, Pages

  Martínez Moreno, Julio M ^a   Muñoz Castañeda, Juan R ^a   Herencia, Carmen ^a   de Oca, Addy Montes ^b   Estepa, Jose C ^b   Canalejo, Rocio ^a   Rodríguez Ortiz, Maria E ^a   Perez Martinez, Pablo ^c   Aguilera Tejero, Escolástico ^b   Canalejo, Antonio ^d   Rodríguez, Mariano ^a   Almadén, Yolanda ^c  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF HUELVA   (Spain)

Author keywords

Calcitriol; Paricalcitol; Vascular calcification; VSMCs; Wnt catenin

Indexed keywords

AXIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CALCITRIOL; CYCLIN D1; DICKKOPF 1 PROTEIN; OSTEOCALCIN; PARICALCITOL; PHOSPHATE; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; VERSICAN; WNT PROTEIN;

AMINO ACID SEQUENCE; AORTA MEDIA; ARTICLE; BLOOD VESSEL CALCIFICATION; CELL ACTIVATION; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

EID: 84867722822     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00684.2011     Document Type: Article

References (63)

1. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signaling inhibition mediated by Dickkopf-1 interaction with LRP6/ Arrow. Nat Cell Biol 3: 683-686, 2001.
2. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 21: 484-490, 2006.
3. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31: 607-617, 1998.
4. Cardús A, Panizo S, Parisi E, Fernandez E, Valdivielso JM. Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 22: 860-866, 2007.
5. Cheng SL, Shao JS, Halstead LR, Distelhorst K, Sierra O, Towler DA. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/fj-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res 107: 271-282, 2010.
6. Ciceri P, Volpi E, Brenna I, Arnaboldi L, Neri L, Brancaccio D, Cozzolino M. Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation. Nephrol Dial Transplant 27: 122-127, 2012.
7. Demer LL, Tintut Y. Vascular calcification: pathobiology of multifaceted disease. Circulation 117: 2938-2948, 2008.
8. Faverman L, Mikhaylova L, Malmquist J, Nurminskaya M. Extracellular transglutaminase 2 activates fj-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett 582: 1552-1557, 2008.
9. Feigenson K, Reid M, See J, Crenshaw EB III, Grinspan JB. Canonical Wnt signalling requires the BMP pathway to inhibit oligodendrocyte maturation. ASN Neuro 3: e00061, 2011.
10. Fretz JA, Zella LA, Kim S, Shevde NK, Pike JW. 1,25-Dihydroxyvi-tamin D3 regulates the expression of low density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Mol Endocrinol 20: 2215-2230, 2006.
11. Friedman MS, Oyserman SM, Hankenson KD. Wnt11 promotes osteoblast maturation and mineralization through R-spondin 2. J Biol Chem 284: 14117-14125, 2009.
12. Gaur T, Lengner CJ, Hovhannisyan H, Bha RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280: 33132-33140, 2005.
13. Goodman WG. The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Semin Dial 17: 209-216, 2004.
14. Henley C, Colloton M, Cattley RC, Shatzen E, Towler DA, Lacey D, Martin D. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/ Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 20: 1370-1377, 2005.
15. Hirata M, Katsumata K, Endo K, Fukushima N, Ohkawa H, Fuka-gawa M. In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3. Nephrol Dial Transplant 18: 1770-1776, 2003.
16. Hopyan S, Gokgoz N, Bell RS, Andrulis IL, Alman BA, Wunder JS. Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours. J Orthop Res 17: 633-638, 1999.
17. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circulation 97: 105-114, 2005.
18. Issa LL, Leong GM, Sutherland RL, Eisman JA. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators. J Bone Miner Res 17: 879-890, 2002.
19. Jono S, Nishizawa Y, Shioi A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98: 1302-1306, 1998.
20. Kamiya N, Kobayashi T, Mochida Y, Yu PB, Yamauchi M, Kronen-berg HM, Mishina Y. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res 25: 200-210, 2010.
21. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA, 2nd Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303-314, 2002.
22. Koleganova N, Piecha G, Ritz E, Schmitt CP, Gross ML. A calcimi-metic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int 75: 60-71, 2009.
23. Komori T. Signaling networks in RUNX2-dependent bone development. J Cell Biochem 112: 750-755, 2011.
24. Larriba MJ, Ordóñez-Morán P, Chicote I, Martín-Fernández G, Puig I, Muñoz A, Pálmer HG. Vitamin D receptor deficiency enhances Wnt/fj-catenin signaling and tumor burden in colon cancer. PLos One 6(8): e23524, 2011.
25. Lau WL, Festing MH, Giachelli CM. Phosphate and vascular calcification: emerging role of the sodium-dependent phosphate cotransporter PiT-1. Thromb Haemost 104: 464-470, 2010.
26. Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene 433: 1-7, 2009.
27. Lopez I, Aguilera-Tejero E, Mendoza FJ, Almaden Y, Perez J, Martin D, Rodriguez M. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol. J Am Soc Nephrol 17: 795-804, 2006.
28. Lopez I, Mendoza FJ, Aguilera-Tejero E, Perez J, Guerrero F, Martin D, Rodriguez M. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int 73: 300-307, 2008.
29. Martin KJ, González EA, Gellens M, Hamm LL, Abboud H, Lindberg J. 19-nor-1,25-dihydroxyvitamin D2 safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol 9: 1427-1432, 1998.
30. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda TB. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 83: 29119-29125, 2008.
31. Mikhaylova L, Malmquist J, Nurminskaya M. Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a. Calcif Tissue Int 81: 372-381, 2007.
32. Mirando AJ, Maruyama T, Fu J, Yu HM, Hsu W. fj-catenin/cyclin D1 mediated development of suture mesenchyme in calvarial morphogenesis. BMC Dev Biol 10: 116, 2010.
33. Mizobuchi M, Finch JL, Martin DR, Slatopolsky E. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 72: 709-715, 2007.
34. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 20: 1453-1464, 2009.
35. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 19: 213-216, 2008.
36. Montes de Oca A, Madueño JA, Martinez-Moreno JM, Guerrero F, Muñoz-Castañeda J, Rodriguez-Ortiz ME, Mendoza FJ, Almaden Y, Lopez I, Rodriguez M, Aguilera-Tejero E. High-phosphate-induced calcification is related to SM22a promoter methylation in vascular smooth muscle cells. J Bone Miner Res 25: 1996-2005, 2010.
37. Pálmer HG, Anjos-Afonso F, Carmeliet G, Takeda H, Watt FM. The vitamin D receptor is a Wnt effector that controls hair follicle differentiation and specifies tumor type in adult epidermis. PLos One 23: e1483, 2008.
38. Pendás-Franco N, Aguilera O, Pereira F, González-Sancho JM, Muñoz A. Vitamin D and Wnt/fj-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res 28: 2613-2623, 2008.
39. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum Dis Clin North Am 38: 13-27, 2012.
40. Prosdocimo DA, Wyler SC, Romani AM, O'Neill WC, Dubyak GR. Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia. Am J Physiol Cell Physiol 298: C702-C713, 2010.
41. Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, George SJ. Regulation of smooth muscle cell proliferation by fj-catenin/ T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circ Res 99: 1329-1337, 2006.
42. Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfan-diarei M, Si X, Luo Z, Luo H, Rennie PS, McManus BM. Regulation of the versican promoter by the fj-catenin-T-cell factor complex in vascular smooth muscle cells. J Biol Chem 280: 13019-13028, 2005.
43. Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18: 1842-1853, 2003.
44. Reynolds JL, Joannides AJ, Skepper JN, Mc-Nair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867, 2004.
45. Rodriguez M, Martinez-Moreno JM, Rodríguez-Ortiz ME, Muñoz-Castañeda JR, Almaden Y. Vitamin D and vascular calcification in chronic kidney disease. Kidney Blood Press Res 34: 261-268, 2011.
46. Rodríguez-Carballo E, Ulsamer A, Susperregui AR, Manzanares-Céspedes C, Sánchez-García E, Bartrons R, Rosa JL, Ventura F. Conserved regulatory motifs in osteogenic gene promoters integrate cooperative effects of canonical Wnt and BMP pathways. J Bone Miner Res 26: 718-729, 2011.
47. Sage AP, Lu J, Tintut Y, Demer LL. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79: 414-422, 2011.
48. Santos A, Bakker AD, de Blieck-Hogervorst JM, Klein-Nulend J. WNT5A induces osteogenic differentiation of human adipose stem cells via rho-associated kinase ROCK. Cytotherapy 12: 924-932, 2010.
49. Shalhoub V, Shatzen E, Henley C, Boedigheimer M, McNinch J, Manoukian R, Damore M, Fitzpatrick D, Haas K, Twomey B, Kiaei P, Ward S, Lacey DL, Martin D. Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols. Calcif Tissue Int 79: 431-442, 2006.
50. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109: 697-711, 2011.
51. Shao JS, Pingsterhaus JM, Cheng SL, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115: 1210-1220, 2005.
52. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. The cyclin D1 gene is a target of the (3-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527, 1999.
53. Slatopolsky E, Finch J, Ritter C, Takahashi F. Effect of 19-nor-1,25(OH)2D2, a new analogue of calcitriol on secondary hyperparathyroidism in uremic rats. Am J Kidney Dis 32: S40-S47, 1998.
54. Soshnikova N, Zechner D, Huelsken J, Mishina Y, Behringer RR, Taketo MM. Crenshaw Genetic interaction between Wnt/(3-catenin, and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limb. Genes Dev 17: 1963-1968, 2003.
55. Tang DZ, Hou W, Zhou Q, Zhang M, Holz J, Sheu TJ, Li TF, Cheng SD, Shi Q, Harris SE, Chen D, Wang YJ. Osthole Stimulates Osteoblast Differentiation and Bone Formation by Activation of β-Catenin-BMP Signaling. J Bone Miner Res 25: 1234-1245, 2010.
56. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shana-han CM. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23: 489-494, 2003.
57. Van Gijn ME, Daemen MJ, Smits JF, Blankesteijn WM. The wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res 55: 16-24, 2006.
58. Villa-Bellosta R, Millan A, Sorribas V. Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. Am J Physiol Cell Physiol 300: C210-C220, 2011.
59. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL. A role for the β-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 90: 340-347, 2002.
60. Williams BO, Insogna KL. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res 24: 171-178, 2009.
61. Wilson PWF, Kauppila LI, O'Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103: 1529-1534, 2001.
62. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, Sakamoto D, Caothien RH, Fuller JH, Reinhard C, Garcia PD, Randazzo FM, Escobedo J, Fantl WJ, Williams LT. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA 98: 14973-14978. 2001.
63. Zebger-Gong H, Müller D, Diercke M, Haffner D, Hocher B, Verber-ckmoes S, Schmidt S, D'Haese PC, Querfeld U. 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: upregulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens 29: 339-348, 2011.